"A Phase 2 Multicenter Trial of Ofatumumab and Prednisone as Initial Therapy of Chronic Graft-vs-Host Disease." by Ariel Perez Perez

Selected Works of Ariel Perez Perez

Follow Contact

Article

A Phase 2 Multicenter Trial of Ofatumumab and Prednisone as Initial Therapy of Chronic Graft-vs-Host Disease.

Blood Advances (2022)

Ariel Perez Perez, Baptist Health South Florida
Additional authors and institutional affiliations

Link

Disciplines

Medicine and Health Sciences

Publication Date

January, 2022

Citation Information

Ariel Perez Perez and Additional authors and institutional affiliations. "A Phase 2 Multicenter Trial of Ofatumumab and Prednisone as Initial Therapy of Chronic Graft-vs-Host Disease." Blood Advances Vol. 11 Iss. 6 (2022) p. 259 - 269
Available at: http://works.bepress.com/ariel-perezperez/20/